Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 340 results found. Search for [ Sun Pharmaceutical Industries ]

Results 1 to 21 of 340
PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
New Delhi, November 7, 2019
Sun Pharma Q2 results: India sales, which accounted for 31.6 per cent of total consolidated sales, rose 35 per cent year-on-year (YoY) to Rs 2,515 crore in September quarter of this fiscal


BusinessToday.In
November 7, 2019
Sun Pharma Q2 result today: The drug major's share price was trading higher ahead of the firm's Q2 earnings


BusinessToday.In
November 6, 2019
AstraZeneca Pharma will sell Sun Pharma's cancer treatment drugs in China.\"The agreement will help to bring cost-effective and quality drugs to patients in China,\" the regulatory filing said.


PTI
October 31, 2019



Joe C Mathew
New Delhi, October 30, 2019
The spectacular rise of a reticent man who has pushed his company to the top but still avoids media glare and limelight


BusinessToday.In
September 6, 2019
The share price of Sun Pharma fell 4.01% to Rs 414.60 after the company accepted the allegations of a SEBI ordered forensic audit on company's financial statements.


E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


BusinessToday.In
New Delhi, August 14, 2019
Paring previous session gains, Sun Pharma share price declined as much as 6.71 per cent to touch an intra-day low of Rs 408.15 apiece on the BSE


BusinessToday.In
New Delhi, August 13, 2019
Sun Pharma Q1 results: Consolidated net sales grew 15.69 per cent to Rs 8,259.30 crore as against Rs 7,138.83 crore in the corresponding quarter; India sales, which accounted for 28 per cent of total sales, climbed 8 per cent YoY to Rs 2,314 crore in April-June period of this fiscal


BusinessToday.In
New Delhi, August 3, 2019
After this move, nearly 80 employees have lost their jobs at Vadodara's R&D unit of Sun Pharma.


Reuters
July 17, 2019
The U.S. Food and Drug Administration (FDA) said it found adulteration and \"significant violations\" of current good manufacturing practice (CGMP) regulations at Strides Pharma Sciences Ltd's plant in Puducherry in south India.


BusinessToday.In
July 15, 2019
Domestic equity indices BSE Sensex and NSE Nifty ended on a bullish note on Monday, driven by heavy gains in index heavyweight Infosys, Sun Pharmaceutical Industries, Maruti Suzuki India, Tata Consultancy Services  and Mahindra & Mahindra . The 30-share index settled 160.48 points higher at 38,896 level and the broader Nifty50 ended at 11,588, registering a gain of 35 points.Commenting on the Market rundown today, Vinod Nair, Head of Research, Geojit Financial Services ...


BusinessToday.In
July 15, 2019
Domestic equity indices BSE Sensex and NSE Nifty ended on a bullish note on Monday, driven by heavy gains in index heavyweight Infosys, Sun Pharmaceutical Industries, Maruti Suzuki India, Tata Consultancy Services  and Mahindra & Mahindra.


BusinessToday.In
New Delhi, July 15, 2019
Global brokerage agency Morgan Stanley has maintained a target price of Rs 505 per share, nearly 24 per cent higher as compared to Friday's closing level of Rs 407.70


PTI
May 31, 2019



PTI
May 29, 2019



PTI
May 28, 2019



BusinessToday.In
New Delhi, May 28, 2019
Sun Pharma's Q4 net profit declined to Rs 635.88 crore from Rs 1,342.50 crore in the same quarter last year; revenue from operations was at Rs 7,044.26 crore versus Rs 6,711.01 crore in Q4FY18


PTI
May 28, 2019



PAGES 1 OF 17  12345